NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
JRCT ID: jRCTs041240110

Registered date:23/10/2024

JCCG EPN23: A phase2 study to evaluate the efficacy and safety of the multimodality therapy using treatment stratification in pediatric ependymoma

Basic Information

Recruitment status Pending
Health condition(s) or Problem(s) studiedintracranial ependymoma
Date of first enrollment01/12/2024
Target sample size100
Countries of recruitment
Study typeInterventional
Intervention(s)Surgical resection, chemotherapy, radiotherapy

Outcome(s)

Primary OutcomeStratum 1: Non unresectable recurrence rate Stratum 2: Event-free survival (EFS) in 2 years Stratum 3: Total removal/Complete response Rate
Secondary OutcomeAssessment of Efficacy Assessment of Safety

Key inclusion & exclusion criteria

Age minimum>= 1age old
Age maximum< 30age old
GenderBoth
Include criteria1) Tumor removal or biopsy for the primary lesion is performed at the time of first occurrence, and the pathological diagnosis of ependymoma is obtained in each institution, and specimens are scheduled to be sent to the central pathology. 2) Registered in the observational study for pediatric solid tumors by Japan Children's Oncology Group (JCCG). 3) Within 6 weeks of tumor removal or biopsy. 4) No evidence of dissemination by head and spinal MRI 5) 1 years or older, less than 30 years. 6) No prior chemotherapy or head radiation therapy for any intracranial tumors. 7) ECOG performance status (PS) of 0, 1, 2, or 3 8) Written informed consent is obtained from the patient or his/her legal guardian.
Exclude criteria1) Active double cancer (synchronous double cancer and metachronous double cancer with disease-free period of 5 years or less). 2) Complicated heart disease requiring treatment. 3) Pregnant or nursing. 4) Cases in which the radiologist considers that it is difficult to perform radiotherapy as specified in the protocol. 5) Judgement of inappropriate inclusion by physician

Related Information

Contact

Public contact
Name Rieko Taniguchi
Address 1007 Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka Shizuoka Japan 411-8777
Telephone +81-55-989-5222
E-mail r.taniguchi@scchr.jp
Affiliation Shizuoka Cancer Center
Scientific contact
Name Ryuta Saito
Address 65 Tsurumai-cho, Showa-ku, Nagoya Aichi Japan 466-8550
Telephone +81-52-741-2111
E-mail epn23@med.nagoya-u.ac.jp
Affiliation Nagoya University Hospital